MTE #24: Optimizing Reproductive Health: Special Considerations for Cholestatic and Autoimmune Liver Disease and Liver Transplant (Ticketed)

Nov 17 2024
Convention Center: Room 33 C
12:45 PM - 1:30 PM
Ticketed Event

World Class Speakers

Monika Sarkar, MD, FAASLD, MAS
Discussion Leader

Monika Sarkar, MD, FAASLD, MAS

University of California, San Francisco
Vandana Khungar, MD, MSc
Discussion Leader

Vandana Khungar, MD, MSc

Yale University

Description

Experts address the timing of pregnancy in relation to liver transplant (LT), graft function, and recurrence of chronic active liver disease post liver transplant (post-LT). Faculty also discuss immunosuppression safety in pregnancy and breastfeeding, and the distinct maternal and perinatal risks of post-LT pregnancy.  

 

Journey Maps

Objectives

  • Describe how to counsel transplant recipients on family planning and pregnancy planning.
  • Review the prevalence of maternal and perinatal risks of post-LT pregnancy.
  • Discuss strategies to optimize pregnancy outcomes in the setting of LT and recurrent chronic active liver disease.
  • Review the safety of routine immunosuppression as well as acute rejection treatment during pregnancy and breastfeeding, including the safety profiles of less commonly used agents.